These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31067540)

  • 1. Estimation of Phenytoin Pharmacokinetic Parameters in Saudi Epileptic Patients.
    Alqahtani S; Alzaidi T; Alotaibi M; Alsultan A
    Pharmacology; 2019; 104(1-2):60-66. PubMed ID: 31067540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of apparent clearance of valproic acid in adult Saudi patients.
    Alqahtani S; Alandas N; Alsultan A
    Int J Clin Pharm; 2019 Aug; 41(4):1056-1061. PubMed ID: 31222537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin dosage adjustment in Saudi epileptics: utilization of steady-state pharmacokinetic parameters.
    Abduljabbar M; Al-Khamis K; Ogunniyi A; Daif AK; Al-Yamani M
    Eur J Neurol; 1999 May; 6(3):331-4. PubMed ID: 10210914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model.
    Odani A; Hashimoto Y; Takayanagi K; Otsuki Y; Koue T; Takano M; Yasuhara M; Hattori H; Furusho K; Inui K
    Biol Pharm Bull; 1996 Mar; 19(3):444-8. PubMed ID: 8924916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly.
    Guk J; Lee SG; Chae D; Kim JH; Park K
    J Pharm Sci; 2019 Aug; 108(8):2765-2773. PubMed ID: 30940470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic Analysis of Phenytoin After Intravenous Administration of Fosphenytoin in Adult and Elderly Epileptic Patients.
    Higuchi K; Yamashita D; Kashihara Y; Kakara M; Hirota T; Hirakawa M; Ieiri I
    Ther Drug Monit; 2019 Oct; 41(5):674-680. PubMed ID: 31095070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the population pharmacokinetic parameters of phenytoin in adult epileptic patients in South Africa.
    Valodia P; Seymour MA; Miller R; McFadyen ML; Folb PI
    Ther Drug Monit; 1999 Feb; 21(1):57-62. PubMed ID: 10051055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of population pharmacokinetic parameters of phenytoin using the parallel Michaelis-Menten and first-order elimination model.
    Valodia PN; Seymour MA; McFadyen ML; Miller R; Folb PI
    Ther Drug Monit; 2000 Jun; 22(3):313-9. PubMed ID: 10850399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers.
    Tanaka J; Kasai H; Shimizu K; Shimasaki S; Kumagai Y
    Eur J Clin Pharmacol; 2013 Mar; 69(3):489-97. PubMed ID: 22918614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-point phenytoin dosage predictions in Singapore Chinese.
    Chan E
    J Clin Pharm Ther; 1997 Feb; 22(1):47-52. PubMed ID: 9292403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling.
    Jun H; Rong Y; Yih C; Ho J; Cheng W; Kiang TKL
    Drugs R D; 2020 Dec; 20(4):343-358. PubMed ID: 33026608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study of the association between the elimination parameters of phenytoin and phenobarbital.
    Methaneethorn J; Panomvana D; Vachirayonstien T
    Drug Metab Pers Ther; 2017 Sep; 32(3):151-156. PubMed ID: 28873066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
    Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
    Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
    el-Sayed YM; Islam SI
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):173-8. PubMed ID: 2714918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of carbamazepine in elderly patients.
    Punyawudho B; Ramsay ER; Brundage RC; Macias FM; Collins JF; Birnbaum AK
    Ther Drug Monit; 2012 Apr; 34(2):176-81. PubMed ID: 22406657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
    Takeuchi M; Yano I; Ito S; Sugimoto M; Yamamoto S; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steady state population kinetics of intravenous phenytoin.
    Frame B; Beal SL
    Ther Drug Monit; 1998 Aug; 20(4):408-16. PubMed ID: 9712466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.
    Ahn JE; Cloyd JC; Brundage RC; Marino SE; Conway JM; Ramsay RE; White JR; Musib LC; Rarick JO; Birnbaum AK; Leppik IE
    Neurology; 2008 Jul; 71(1):38-43. PubMed ID: 18591503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients.
    Deleu D; Aarons L; Ahmed IA
    Arch Med Res; 2005; 36(1):49-53. PubMed ID: 15777995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.